With presentations from Industry experts, including a keynote from Ken Getz, Professor of Tufts Center for the Study of Drug Development, RBQM Live is the virtual event of 2022 that you absolutely cannot afford to miss.

Experts
[FROM ACROSS THE]
Industry
9
[SESSIONS]
#RBQMLIVE
[SPEAKERS]
The Lineup

Ken Getz
[Executive Director and Professor, Tufts Center for the Study of Drug Development]

Demetris Zambas
[Global Clinical Operations Leader, Pfizer]

Steve Gilbert
[Senior Director Statistics, Pfizer ]

Olivia Feiro
[Director, Risk Management and Analytics, CSL Behring]

Amit Gulwadi
[Vice President- Head of Transformation, Alexion]

Cris McDavid
[Cris McDavid, Associate Director, Global Clinical Operations, RBQM, Parexel]

Blake Jensen
[Quality and Compliance Executive, Adagio]

Lynne Cesario
[Senior Director, Risk Based Monitoring Program Lead, Pfizer]

Kathy Taylor
[Senior Director/Head Risk Evaluation and Adaptive Integrated Monitoring, Merck]

Peter Stokman
[Business Lead Clinical Data Reporting & Visualization Environment - Bayer]

Linda Sullivan
[Senior Advisor, Metrics & Performance Management WCG]

Joseph Dustin
[Vice President of Product Strategy for eCOA at Medable ]

Jonathan Rowe
[Principal, Head of R&D Quality, Operations and Risk Management at ZS]

Marion Wolfs
[Integrated Data Analytics and Reporting (IDAR) Organization - Janssen ]

Nicole Stansbury
[ACRO RBQM Working Group Member ]

Mayank Anand
[Vice President and Global Head for GSK]

Craig H. Lipset
[Managing Partner, Clinical Innovation Partners]

Richard Young
[Vice President, Strategy, Vault CDMS, Veeva Systems]

Jessica Jackson
[Jessica Jackson, Head of Clinical Operations, Galderma ]